“Hedgehog pathway”: a potential target of itraconazole in the treatment of cancer Xin WeiWu LiuZeyao Tang Review – Cancer Research 20 January 2020 Pages: 297 - 304
Prostate specific membrane antigen (PSMA) in urothelial cell carcinoma (UCC) is associated with tumor grading and staging Henner SchreiberJörg HänzeAxel Hegele Original Article – Cancer Research 02 January 2020 Pages: 305 - 313
Crosstalk of estrogen receptors and Wnt/β-catenin signaling in endometrial cancer Mariz KasohaChrisoula DernektsiIngolf Juhasz-Böss Original Article – Cancer Research 21 December 2019 Pages: 315 - 327
YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling Cheng ZhangXiaoting LinLin Shen Original Article – Cancer Research Open access 08 January 2020 Pages: 329 - 342
Histone deacetylase inhibitors dysregulate DNA repair proteins and antagonize metastasis-associated processes Nicole KiwelerDésirée WünschOliver H. Krämer Original Article – Cancer Research Open access 13 January 2020 Pages: 343 - 356
Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study Yi ZhangShan-Shan SuoJie Jin Original Article – Cancer Research Open access 14 January 2020 Pages: 357 - 365
Long non-coding RNA MALAT1 facilitates the tumorigenesis, invasion and glycolysis of multiple myeloma via miR-1271-5p/SOX13 axis Na LiuSong FengYufeng Liu Original Article – Cancer Research Open access 18 January 2020 Pages: 367 - 379
TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma Paolo Boscolo-RizzoSilvia GiuncoAnita De Rossi Original Article – Cancer Research 20 January 2020 Pages: 381 - 389
Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradox Stephan KrugerKaroline SchirleStefan Boeck Original Article – Clinical Oncology 23 October 2019 Pages: 391 - 399
Prognostic value of tumor cavitation in extensive-stage small-cell lung cancer patients treated with anlotinib Dongfang ChenJianlin XuRunbo Zhong Original Article – Clinical Oncology 06 November 2019 Pages: 401 - 406
Co-occurring genetic alterations and primary EGFR T790M mutations detected by NGS in pre-TKI-treated NSCLCs Yuan TangNanying CheDongmei Lin Original Article – Clinical Oncology 06 November 2019 Pages: 407 - 416
Clinical outcomes and prognostic factors of stereotactic body radiation therapy combined with gemcitabine plus capecitabine for locally advanced unresectable pancreatic cancer Ze-Tian ShenHan ZhouGui-Chun Huang Original Article – Clinical Oncology 30 October 2019 Pages: 417 - 428
Superiority of intensity-modulated radiation therapy in nasopharyngeal carcinoma with skull-base invasion Shufang LiaoYuan XieWei Jiang Original Article – Clinical Oncology 01 November 2019 Pages: 429 - 439
First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or < 1% PD-L1-expressing metastatic non-small-cell lung cancers Thierry LandreGaetan Des GuetzChristos Chouaïd Original Article – Clinical Oncology 04 November 2019 Pages: 441 - 448
Treatment of refractory germ-cell tumours with single-agent cabazitaxel: a German Testicular Cancer Study Group case series Christoph OingMarcus HentrichChristoph Seidel Original Article – Clinical Oncology 14 December 2019 Pages: 449 - 455
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer Hisao ImaiSatoshi WasamotoKyoichi Kaira Original Article – Clinical Oncology 18 December 2019 Pages: 457 - 466
Tissue factor activity on microvesicles from cancer patients Fanny EnderAnnika FreundFrank Gieseler Original Article – Clinical Oncology Open access 16 November 2019 Pages: 467 - 475
Impact of clinical complete response on treatment outcomes in patients with locally advanced HPV-negative oropharyngeal squamous cell carcinoma Francesca De FeliceDaniela MusioVincenzo Tombolini Original Article – Clinical Oncology 04 November 2019 Pages: 477 - 483
Comparative analysis of causes and predictors of early death in elderly and young patients with acute promyelocytic leukemia treated with arsenic trioxide Bo JinYingmei ZhangJin Zhou Original Article – Clinical Oncology 04 November 2019 Pages: 485 - 492
Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients Vincenzo CatalanoFrancesca BergamoFrancesco Graziano Original Article – Clinical Oncology 06 November 2019 Pages: 493 - 501
Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib Julia EismannYujing J. HengGerburg M. Wulf Original Article – Clinical Oncology Open access 19 November 2019 Pages: 503 - 514
Insufficient examined lymph node count underestimates staging in pN3a patients after curative gastrectomy: a multicenter study with external validation Yinping DongYiran QiuHan Liang Original Article – Clinical Oncology 07 December 2019 Pages: 515 - 528
Impact of pathologic complete response on survival after neoadjuvant chemotherapy in early-stage breast cancer: a population-based analysis Nathalie LeVasseurJ. SunS. Chia Original Article – Clinical Oncology 18 November 2019 Pages: 529 - 536
Percent tumor volume vs American Joint Committee on Cancer staging system subclassification for predicting biochemical recurrence in patients with pathologic T2 prostate cancer Se Young ChoiByung Hoon ChiChoung-Soo Kim Original Article – Clinical Oncology 08 January 2020 Pages: 537 - 543